Brandes Investment Partners LP Sells 553,126 Shares of Syneron Medical Ltd. (ELOS)
Brandes Investment Partners LP trimmed its holdings in shares of Syneron Medical Ltd. (NASDAQ:ELOS) by 16.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,901,971 shares of the medical equipment provider’s stock after selling 553,126 shares during the quarter. Brandes Investment Partners LP owned approximately 8.24% of Syneron Medical worth $31,921,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. CNH Partners LLC bought a new stake in Syneron Medical during the second quarter valued at approximately $16,196,000. K2 Principal Fund L.P. bought a new position in shares of Syneron Medical in the second quarter worth approximately $12,076,000. Vivaldi Asset Management LLC bought a new position in shares of Syneron Medical in the second quarter worth approximately $9,644,000. SG Americas Securities LLC bought a new position in shares of Syneron Medical in the second quarter worth approximately $5,600,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Syneron Medical by 1,259.7% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 501,440 shares of the medical equipment provider’s stock worth $5,491,000 after purchasing an additional 464,561 shares during the period. Institutional investors own 69.17% of the company’s stock.
Syneron Medical Ltd. (NASDAQ ELOS) opened at $11.00 on Thursday. Syneron Medical Ltd. has a 12-month low of $6.18 and a 12-month high of $11.43.
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Want to see what other hedge funds are holding ELOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneron Medical Ltd. (NASDAQ:ELOS).
Receive News & Stock Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related stocks with our FREE daily email newsletter.